FEMTOprint and Millimeter-sized particle sensor commissioned by CEA-LETI.

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted